Evidence map›Paper›PMID 37555174›Full record

ArticleFrontiers in neuroimaging2022

Investigation of Human Intrathecal Solute Transport Dynamics Using a Novel

Akari Seiner, Goutham Kumar Reddy Burla, Dev Shrestha, Mayumi Bowen, Joshua D Horvath, Bryn A Martin

Abstract read
In one paragraph

Article in Frontiers in neuroimaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Akari SeinerDepartment of Chemical and Biological Engineering, University of Idaho, Moscow, ID, United States.
Goutham Kumar Reddy BurlaDepartment of Chemical and Biological Engineering, University of Idaho, Moscow, ID, United States.
Dev ShresthaDepartment of Chemical and Biological Engineering, University of Idaho, Moscow, ID, United States.
Mayumi BowenGenentech, Inc., A Member of the Roche Group, South San Francisco, CA, United States.
Joshua D HorvathGenentech, Inc., A Member of the Roche Group, South San Francisco, CA, United States.
Bryn A MartinDepartment of Chemical and Biological Engineering, University of Idaho, Moscow, ID, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Understanding the relationship between cerebrospinal fluid (CSF) dynamics and intrathecal drug delivery (ITDD) injection parameters is essential to improve treatment of central nervous system (CNS) disorders. Methods: An anatomically detailed Results: For all experiments conducted with ITDD administration in the lumbar spine, %ID to the brain did not exceed 11.6% at a time point 3-h post-injection. Addition of a 12 mL flush slightly increased solute transport to the brain up to +3.9%ID compared to without a flush ( Conclusion: The

Indexed as

biofluid mechanicscentral nervous systemcerebrospinal fluid—CSFdrug delivery & targetingintrathecal (i.t.) injectionin vitrolumbar puncture (LP)neuroimaging (anatomic)

Identifiers

PMID37555174
PMCPMC10406265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.